Skip to main content

Closed

CTKB: Cytek Biosciences, Inc. Stock Analysis | finqOS

Healthcare · Medical - Devices

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-21.5%

ROIC-11.4%

Financially safe

Stretched

Debt / equity0.11×

Interest coverage-23.2×

Current ratio4.69×

Cytek Biosciences, Inc.

CTKBNASDAQ Global Select·USD·Closed

Cytek Biosciences, Inc.

CTKBNASDAQ·USD·Closed

$4.22

−2.09%

$4.22

−$0.09 (2.09%)

52W Range

32thpctl

Volume

0.41×avg

Mkt Cap

544.98MUSD

P/E

-7.3TTM

Div Yield

–ann

52W Range

32thpctl

Volume

0.41×avg

Market Cap

544.98MUSD

P/E Ratio

-7.3TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings